Use your browser's back button to choose another title or click here for a New Search.

How to Get the Brochure

 Open PDF


Bookmark and Share

Prescription Opioid Addiction Treatment Study: Should I Participate?

NIDA Center for the Clinical Trials Network (NIDA CCTN).

This brochure, intended for participants thinking about joining the CTN-0030 (Prescription Opioid Addiction Treatment Study (POATS)) protocol, provides an overview of the project and answers any questions participants might have. The main objective of this trial is to identify effective treatment regimen for sublingual Buprenorphine/Naloxone (BUP/NX) in patients dependent on prescription opioids. The first phase will assess the currently prevailing 1-month detoxification practice. The second phase will compare the effectiveness of standard medical (BUP/NX) management and medical management (BUP/NX) enhanced by intensive individual drug counseling (IDC) in those patients that were not successful in the previous phase. (Brochure, PDF, English)

Keywords: Buprenorphine | Buprenorphine/Naloxone | Opioid dependence | Opioid detoxification | Participant information | Pharmacological therapy

Document No: 155

Submitted by the CTN Dissemination Librarians, 12/8/2006.

NIDA Center for the Clinical Trials Network (CCTN) search
NIDA-CTN-0030 search www
New England Consortium (formerly Northern New England) (Lead) search www
Pacific Region (Lead) search www
Appalachian Tri-State search www
Greater New York (formerly Long Island and New York) search www
Ohio Valley search www
Pacific Northwest search www
Southern Consortium search www
Texas search www
Western States (formerly California/Arizona and Oregon/Hawaii) search www

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 4/2009 --